AI Screening System for Diabetic Eye Disease Enters Russian Market
An AI-powered tool is designed to detect early-stage eye damage in people with diabetes.
Siberian State Medical University has brought a telemedicine clinical-decision support system called Oftalmik+ (Ophthalmic+) to the Russian market to diagnose diabetic retinopathy. The university’s press office said the team has received a registration certificate from Roszdravnadzor, Russia’s healthcare regulator, for the technology.
The Oftalmik+ digital screening model combines specialized software with a digital portal. Using artificial intelligence, the system analyzes retinal images and identifies abnormalities at an early stage. It highlights areas in eye-fundus images that show damage or changes in the retina and estimates the likelihood of diabetic retinopathy – a disease that damages the retina.
Scaling the System and Expanding Its Capabilities
Researchers added a secure medical portal, refined the neural-network model, integrated a retinal imaging device into the platform, and introduced a clinical decision-support system that visualizes pathological changes.
For now, the system is being tested in Kostroma and Sakhalin regions as well as in Kamchatka Krai. The developers plan to expand the project to other regions. Researchers are also exploring whether the algorithms could detect additional conditions – retinal image analysis may help assess the risk of cardiovascular complications.
